{
  "id": 8790,
  "note": "Designations can be overlapping; a drug can receive multiple designations or no designation at all. CDER is part of the [US Food and Drug Administration (FDA)](#dod:us-fda).",
  "slug": "new-drugs-approved-in-the-united-states-by-designations",
  "title": "New drugs approved in the United States, by designations",
  "yAxis": {
    "min": 0
  },
  "$schema": "https://files.ourworldindata.org/schemas/grapher-schema.009.json",
  "maxTime": 2024,
  "minTime": 1985,
  "version": 78,
  "subtitle": "The annual number of new drugs approved by the Center for Drug Evaluation and Research (CDER), that fall under each designation, including [Orphan Drugs](#dod:orphan-drug), [Fast Track](#dod:fda-fast-track), [Accelerated Approval](#dod:fda-accelerated-approval), [Breakthrough Therapy](#dod:breakthrough-therapy), and [Qualified Infectious Disease Product](#dod:qualified-infectious-disease-product).",
  "chartTypes": [
    "LineChart"
  ],
  "dimensions": [
    {
      "property": "y",
      "variableId": 1084496
    }
  ],
  "entityType": "designation",
  "isPublished": true,
  "internalNotes": "This does NOT include biologics such as vaccines or gene therapies which are approved by the Center for Biologics Evaluation and Research (CBER).",
  "entityTypePlural": "designations",
  "selectedEntityNames": [
    "Accelerated approvals",
    "Breakthrough therapy approvals",
    "Fast track approvals",
    "Qualified infectious disease product approvals",
    "Orphan drug approvals",
    "All new drug approvals"
  ],
  "selectedEntityColors": {
    "Total drug approvals": "#808080",
    "All new drug approvals": "#6e6e6e"
  },
  "hideAnnotationFieldsInTitle": {
    "time": true
  }
}